QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 clinical-results-of-double-layer-micronet-stents-in-complex-anatomy--science-direct

https://www.sciencedirect.com/science/article/abs/pii/S0890509625004200

 inspiremd-receives-fda-premarket-application-approval-for-cguard-prime-carotid-stent-system

InspireMD, Inc. (the "Company") (NASDAQ:NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of...

 piper-sandler-maintains-overweight-on-inspiremd-lowers-price-target-to-4

Piper Sandler analyst Adam Maeder maintains InspireMD (NASDAQ:NSPR) with a Overweight and lowers the price target from $4.5 ...

 inspiremd-q1-eps-022-misses-020-estimate-sales-153m-beat-145m-estimate

InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) b...

 inspiremd-q4-2024-gaap-eps-019-beats-020-estimate-sales-195m-beat-182m-estimate

InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION